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Available online 11 August 2016Patients with borderline personality disorder (BPD) frequently exhibit impulsive behavior, and self-reported im-
pulsivity is typically higher in BPD patients when compared to healthy controls. Previous functional neuroimag-
ing studies have suggested a link between impulsivity, the ventral striatal response to reward anticipation, and
prediction errors. Here we investigated the striatal neural response to monetary gain and loss anticipation and
their relationship with impulsivity in 21 female BPD patients and 23 age-matched female healthy controls
using functional magnetic resonance imaging (fMRI). Participants performed a delayed monetary incentive
task in which three categories of objects predicted a potential gain, loss, or neutral outcome. Impulsivity was
assessed using the Barratt Impulsiveness Scale (BIS-11). Compared to healthy controls, BPD patients exhibited
signiﬁcantly reduced fMRI responses of the ventral striatum/nucleus accumbens (VS/NAcc) to both reward-
predicting and loss-predicting cues. BIS-11 scores showed a signiﬁcant positive correlation with the VS/NAcc re-
ward anticipation responses in healthy controls, and this correlation, while also nominally positive, failed to
reach signiﬁcance in BPD patients. BPD patients, on the other hand, exhibited a signiﬁcantly negative correlation
between ventral striatal loss anticipation responses and BIS-11 scores, whereas this correlation was signiﬁcantly
positive in healthy controls. Our results suggest that patientswith BPD show attenuated anticipation responses in
the VS/NAcc and, furthermore, that higher impulsivity in BPD patientsmight be related to impaired prediction of
aversive outcomes.







Functional magnetic resonance imaging
Brain-behavior correlations1. Introduction
Borderline personality disorder (BPD) causes considerable and
prolonged distress to the affected individuals and, at the same time,
often poses a diagnostic and therapeutic challenge to clinicians
(Jordanova and Rossin, 2010). One reason for the difﬁculties in diagnos-
ing BPD is the clinical heterogeneity of the disorder. Both the Interna-
tional Classiﬁcation of Diseases (ICD-10; World Health Organization,
1992) and the Diagnostic and Statistical Manual of Mental Disordersiologie, Brenneckestr. 6, 39118
tt).
. This is an open access article under(DSM-IV; American Psychiatric Association, 2000; see also DSM-5;
American Psychiatric Association, 2013), require the fulﬁllment of ﬁve
out of nine diagnostic criteria, resulting in –at least theoretically– 126
different combinations and clinical representations. According to both
DSM-IV and ICD-10, BPD is characterized by behavioral impulsivity, in-
stability in interpersonal relationships, chronic feeling of emptiness, and
aggression, most notably autoaggressive behavior, including suicide at-
tempts or gestures (Lieb et al., 2004; Mauchnik and Schmahl, 2010).
Impulsivity is considered a key symptom of BPD and has been impli-
cated in neurobehavioral models of the disorder (Lieb et al., 2004). Ac-
cording to DSM-IV, impulsivity in at least two potentially self-
damaging areas such as excessive spending, promiscuity, substance
abuse, binge eating, reckless driving, or physically self-damaging acts
is required to fulﬁll the diagnostic criteria for BPD. Impulsivity has
been deﬁned as a failure to resist an impulse, despite potentiallythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2007; Moeller et al., 2001). Furthermore, criteria suggested to deﬁne
impulsivity include (i) deﬁcient tolerance for delay of gratiﬁcation and
(ii) the inability to inhibit or delay voluntary behavior (Ho et al., 1998).
In clinical settings, the Barratt Impulsiveness Scale (BIS-11) (Barratt,
1993; Patton et al., 1995) is a commonly applied self-report tool to as-
sess impulsivity-related cognitive and behavioral traits. Impulsivity as
assessed with the BIS-11 can be further subdivided into attentional,
motor, and non-planning impulsivity, but most clinical studies employ
the sum score. Compatible with the clinical observation of frequent im-
pulsive behavior in BPD, higher BIS-11 scores have frequently been ob-
served in BPDpatients compared to healthy controls (Henry et al., 2001;
Berlin et al., 2005;McCloskey et al., 2009; Jacob et al., 2010; Lynamet al.,
2011; Sebastian et al., 2013) and also to other patient groups like pa-
tients with bipolar II disorder (Henry et al., 2001; Wilson et al., 2007;
Boen et al., 2015) or even patients with orbitofrontal cortex lesions
(Berlin et al., 2005). Several studies of impulsivity in BPD using labora-
tory tasks have provided direct evidence for behavioral manifestations
of impulsivity, such as impaired response inhibition (Leyton et al.,
2001; Hochhausen et al., 2002; Rentrop et al., 2008), difﬁculties in feed-
back-guided decisionmaking (Haaland and Landro, 2007;Maurex et al.,
2009; Svaldi et al., 2012; Mak and Lam, 2013), and higher levels of im-
pulsive aggression (Dougherty et al., 1999; New et al., 2009) in BPD pa-
tients compared to clinical and nonclinical controls. Most prominently,
BPD patients are more likely to make disadvantageous, risky choices
in gambling tasks (Legris et al., 2012; Haaland and Landro, 2007;
Maurex et al., 2009; Schuermann et al., 2011), even in the presence of
explicit rules and constantly provided feedback (Svaldi et al., 2012).
Svaldi and colleagues linked their observations to the clinical phenom-
enon that BPD patientsmake risky or self-harming decisions despite ex-
plicitly knowing their adverse outcomes. On the other hand, in the
absence of choice or risk-taking behavior there is considerably less evi-
dence for heightened impulsivity in BPD patients compared to healthy
controls (Hochhausen et al., 2002; Kunert et al., 2003; Volker et al.,
2009; McCloskey et al., 2009; Jacob et al., 2010, 2013; Beblo et al.,
2011; Legris et al., 2012). These discrepancies may be explained by co-
morbidities, particularly attention deﬁcit hyperactivity disorder
(ADHD), medication, but also by negative emotional states at the time
of testing (Sebastian et al., 2013). Like patients with major depressive
disorder (MDD), BPD patients typically exhibit severe negative affective
states, but, compared to MDD, negative affect in BPD is often character-
ized by more pronounced feelings of anger, hostility, and self-devalua-
tion, which may give rise to impulsive behavior (Bellodi et al., 1992;
Sullivan et al., 1994).
Pathological manifestations of impulsivity-like phenotypes have
been described not only in BPD, but in several psychiatric disorders, in-
cluding alcohol dependence (Beck et al., 2009) and ADHD (Plichta and
Scheres, 2014). Human neuroimaging studies in both healthy partici-
pants and psychiatric patient populations have provided a functional
neuroanatomical link between impulsive phenotypes and the process-
ing of appetitive and aversive stimuli in the mesolimbic reward system
and its core structure, the ventral striatum/nucleus accumbens (VS/
NAcc). Activations of the VS/NAcc have primarily been observed during
dopamine-dependent rewarded tasks, with a dual role of the VS/NAcc in
signaling both reward prediction and prediction errors (Knutson et al.,
2001; Pessiglione et al., 2006; Schott et al., 2007, 2008). Importantly,
converging evidence suggests that impulsivity modulates VS/NAcc re-
ward responses differentially in healthy individuals as compared to psy-
chiatric populations. In healthy individuals, most studies linking striatal
reward processing to impulsivity suggest that VS response to reward
shows a positive correlation with self-reported impulsivity (Abler et
al., 2006; Hariri et al., 2006; Forbes et al., 2009; Plichta and Scheres,
2014). On the other hand, higher impulsivity in addiction (Beck et al.,
2009) and ADHD (Plichta and Scheres, 2014) is apparently accompa-
nied by reduced VS/NAcc activation during reward anticipation and
feedback processing.It must be kept in mind that, given the rather broad deﬁnition of the
term impulsivity (Barratt, 1993), the clinical forms of impulsivity in BPD
and the experimentally used deﬁnitions might reﬂect, at least partly,
distinct (neuro)-psychological phenomena (Sebastian et al., 2013;
Stahl et al., 2014). Nevertheless, the replicated observations linking
pathological impulsivity to functional alterations in the mesolimbic re-
ward system highlight the possibility that dysfunctional ventral striatal
processing of gains and losses might contribute to the psychopathology
of BPD. Thus far, only few studies have investigated the neural correlates
of striatal reward processing in BPD patients. A study employing event-
related potentials (ERPs) revealed that the propensity to perform risky
decisions might result from dysfunctional processing of positive and
negative feedback in BPD patients (Schuermann et al., 2011). Völlm
and colleagues conducted a functional magnetic resonance imaging
(fMRI) study on reward processing in male patients with a Cluster B
personality disorder (Borderline and/or antisocial personality disorder).
Group comparisons revealed hypoactivation of the striatum and mid-
brain in the patients during a rewarded compared to a control task. Pa-
tients additionally showed reduced activation of the left medial
orbitofrontal cortex (OFC), the left dorsolateral prefrontal cortex
(DLPFC), the right frontal pole, as well as the anterior cingulate cortex
(ACC) (Völlm et al., 2007). While that study provided initial evidence
for dysfunctional striatal reward processing in Cluster B personality dis-
orders, several questions remain open. The relatively small study sam-
ple of eight male participants included not only patients with BPD, but
also antisocial personality disorder, and the resultsmay thus not be spe-
ciﬁc to BPD. Second, the study employed a blockeddesign and did there-
fore not allow the authors to separate effects of reward (or loss)
anticipation from feedback effects. In the study byVöllm and colleagues,
impulsivity was related to reduced prefrontal activation in the Cluster B
patient group, but the authors provided no information regarding a po-
tential relationship between impulsivity and gain or anticipation re-
sponses in the striatum. There is to date only one other study
investigating striatal reward processing in BPD (Enzi et al., 2013). In
that study, the sample was more homogenous and included 17 female
BPD patients and age-matched healthy female controls. Compared to
controls, patients exhibited a reduced differentiation betweenanticipat-
ed rewards versus neutral outcomes in the VS/NAcc and, when cues
were presented together with emotional pictures, a blunted reward an-
ticipation response in the rostral ACC.
Given the sensitivity of BPD patients to aversive events and their dif-
ﬁculties in regulating negative emotions (Schmahl et al., 2014), it seems
to be of particular importance to investigate not only gain, but also loss
anticipation in relation to a potential association with impulsivity. At
this point little is known about a potential relationship between loss
processing and impulsivity-related phenotypes in psychiatric popula-
tions. One study in individuals with pathological levels of psychopathy
(assessed with the Psychopathy Check List – Revised, PCL-R; Hare,
2003) demonstrated differential relationship between individual psy-
chopathy scores and ventral striatal responses to gains and losses, re-
spectively (Pujara et al., 2014). The clinical construct of psychopathy
as deﬁned in the PCL-R shows considerable overlap with antisocial per-
sonality disorder, and consists of two factors (Factor 1: “fearless domi-
nance”: blunted affect, stress immunity, narcissism; and Factor 2:
impulsivity, boredom susceptibility, aggressiveness), with BPD patients
typically scoring high on Factor 2 (Hunt et al., 2015; Harpur et al., 1989).
In the present study, we aimed to investigate the relationship be-
tween altered striatal anticipation of gains and losses in BPD and self-re-
ported impulsivity. Based on previous research (Völlm et al., 2007; Enzi
et al., 2013), we hypothesized that BPD patients would exhibit reduced
reward anticipation responses in the VS/NAcc. At the psychometric
level, we expected signiﬁcantly higher levels of self-reported impulsiv-
ity in BPD patients compared to an age-matched group of healthy fe-
male control participants with comparable intelligence and
educational background. Additionally, we hypothesized that ventral
striatal reward or loss anticipation would correlate with self-reported
Table 2
Comorbidities of the BPD-patients (N = 21).
Diagnosis N %
AXIS I Major depressive disorder (F32.x, F33.x) 12 57
Eating disorder (F50.x) 9 43
Alcohol abuse (F10.1) 4 19
Drug abuse (F19.1) 4 19
Posttraumatic stress disorder (F43.1) 2 10
Social anxiety disorder (F40.1) 2 10
AXIS II Avoidant personality disorder (F60.6) 1 5
Histrionic personality disorder (F60.4) 1 5
Without comorbidities 4 19
Diagnosis based on DSM-IV-criteria; Axis I: substance-related disorders, affective disor-
ders, eating disorders, schizophrenia, phobic disorders, posttraumatic stress disorder, eat-
ing disorders, attention deﬁcit hyperactivity disorder; Axis II: personality disorders.
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ous studies investigating the relationship between impulsivity and
mesolimbic reward system function in other psychiatric populations
(Beck et al., 2009; Forbes et al., 2009; Pujara et al., 2014; Sebastian et




Because in clinical settings BPD is more common in women
(Schmahl and Bremner, 2006; Skodol and Bender, 2003) and because
the clinical presentation varies to some extent between sexes
(Mancke et al., 2015), only female patients were included. The ﬁnal
study sample consisted of 21 female patients with BPD (age range 18
to 43 years) and 23 healthy controls (age range 20 to 46 years).
Table 1 displays the demographic characteristics of both groups. BPD
patients were recruited at the Department of Psychiatry and Psycho-
therapy, Charité - Universitätsmedizin Berlin or referred by privately
practicing psychiatrists and psychotherapists. All patients met the
DSM-IV criteria for BPD. Comorbid Axis I and Axis II diagnoses were
assessed according to DSM-IV criteria. To assess Axis-I disorders, we
employed the German version of theMini International Neuropsychiat-
ric Interview (MINI, Ackenheil et al., 1999) in the patients recruited
from the inpatient ward of the Department of Psychiatry, Charité Cam-
pus Benjamin Franklin, and the Structural Clinical Interview for DSM-IV,
Part I (SCID-I; First et al., 1997; German versionWittchen et al., 1997), in
the patients referred from external practitioners. Axis-II comorbidities
were assessed using SCID-II in all patients. BPD-related psychopatholo-
gy was quantiﬁed by self-report questionnaires, speciﬁcally the Border-
line Symptom List (BSL; Bohus et al., 2001), the Barratt Impulsiveness
Scale (BIS-11, Patton et al., 1995), and the Beck Depression Inventory
(BDI, Hautzinger et al., 1994). Diagnosis of BPDwas conﬁrmed by a con-
sultant psychiatrist with extensive experience in the diagnosis and
treatment of BPD. Co-morbid DSM-IV Axis I or Axis II disorders in the
patients are shown in Table 2.
Exclusion criteria were history of major psychoses (schizophrenia,
bipolar disorder, schizoaffective disorder), lifetime diagnosis of adult
ADHD, illicit substance use disorder within six months prior to partici-
pation or alcohol abuse at the time of study. Criteria for adult ADHD
was guided by the diagnostic indicators outlined in the adult ADHD cri-
terion range, German Society for Psychiatry, Psychotherapy, and Neu-
rology (Ebert et al., 2003). This process includes an adult ADHD-
Checklist for DSM-IV (ADHD-CL; Hesslinger et al., 2002) and a semi-
structured clinical interview based on DSM-IV-TR adult ADHD criteria
(American Psychiatric Association, 2000). Patients further had to be
free of psychotropic medication for at least two weeks before participa-
tion (six weeks in case of ﬂuoxetine; six months in case of depot
neuroleptics).
Exclusion criteria for control subjects were any current or past DSM-
IV Axis I or Axis II psychiatric disorders (as screened with the SCID I andTable 1
Demographic and clinical characteristics.
HC (N= 23) BPD (N=
Age 25.78 (5.75) 25.67 (5.9
Smoking 7 never





LPS (PR subtest 3 + 4) 86.01 (13.59) 77.41 (20.
MWT-B (IQ) 108.83 (12.58) 101.95 (13
BIS-11-sum 61.43 (8.55) 80.14 (12.
BDI-sum 3.52 (3.41) 30.38 (10.
BSL-sum 30.57 (16.07) 208.05 (75
Mean scores of psychometric measures for the BPD and HC group. Standard deviations are g
“Mehrfachwahlwortschatztest” form B; BIS-11: Barratt Impulsiveness Scale-11; BDI: Beck DepII; Wittchen et al., 1997), neurological disorders or medical conditions
inﬂuencing cerebral metabolism (e.g., diabetes, systemic corticosteroid
medication) and the diagnosis of borderline personality disorder in a
ﬁrst degree relative. MRI contraindications and pregnancy were exclu-
sion criteria for both patients and controls.
The BPD and control group were highly comparable with respect to
age, crystalline intelligence (assessedwith theMultiple-Choice Vocabu-
lary Intelligence Test/“Mehrfachwahl-Wortschatz-Intelligenztest,”
MWT-B; Lehrl, 2005), and ﬂuid intelligence (assessed with subtests 3
and 4 of the Performance Testing System/“Leistungsprüfsystem”, L-P-
S; Horn, 1983). Intelligence measures were considered to be amore ap-
propriatemeasure than years of education, as patients often had disrup-
tions of their educational and professional careers resulting from
disorder-related periods of prolonged illness and/or hospitalization.
There was a signiﬁcant difference in smoking habits (see Table 1) that
was taken into account in our data analyses (see below).
All subjects gave written informed consent prior to study participa-
tion. The study was carried out in accordance with the Declaration of
Helsinki and approved by the ethics committee of the Charité -
Universitätsmedizin Berlin.
2.2. Experimental paradigm
Weused a categorical version of themonetary incentive delay (MID)
task (Knutson et al., 2001;Wittmann et al., 2005) to invoke anticipation
of reward (gain trials), of avoidable punishment (loss trials), or of a neu-
tral outcome (neutral trials) in BPD patients and healthy controls. Stim-
ulus presentation was carried out using the experimental control
software Presentation (Neurobehavioral Systems Inc., Albany, CA).
Before entering the scanner, participants were informed that they
could actually win or lose money and that their monetary outcome
would depend on their performance in a simple reaction time task,
with the condition (gain, loss, or neutral) being signaled by a picture
of a simple object at the beginning of the task. Task details are given
in Fig. 1. After entering the scanner, participants performed a short prac-
tice version of theMID task in order to reduce learning effects during the
actual task and to estimate the start value of the automatically adapted21) Statistics
8) t42 = 0.07, n. s.
r occasional
χ2 = 9.23, p= 0.010
02) t42 = 1.68, n. s.
.91) t42 = 1.72, n. s.
72) t42 =−5.77, p b 0.001
93) t23.54 =−10.79 (unequal variance assumed), p b 0.001
.91) T21.64 =−10.50 (unequal variance assumed), p b 0.001
iven in parentheses. LPS: “Leistungsprüfsystem” (subtests 3 + 4: reasoning); MWT-B:
ression Inventory; BSL: Borderline Symptom List.
Fig. 1. Example study trial sequence. Each trial startedwith a cue picture (three categories, indicating gain, loss, or neutral outcome, respectively). After a variable delay, participants had to
respond to a target number and indicate via button presswhether the numberwas larger or smaller than 5. After a further variable delay, positive, negative, or neutral feedbackwas given,
depending upon subjects' response accuracy and speed. In 10 reward and loss trials, respectively, a high gain or loss feedback was given.
727M.C. Herbort et al. / NeuroImage: Clinical 12 (2016) 724–736reaction time (RT) threshold (see below). Once in the scanner, anatom-
ical and functional scans were collected.
The actualMID task consisted of two runs comprising 102 trials each,
yielding a total of 204 trials. Three out of six different picture categories
(vehicles, kitchen devices, clothes, furniture, bags, or musical instru-
ments; example pictures are displayed in Fig. 1) served as cues signaling
(potential) reward, (avoidable) loss, and neutral outcome. The catego-
ries were chosen based on the availability of a large number of distinct
images in each category. Each participant was assigned three categories
randomly (counterbalanced across participants, to exclude category-
speciﬁc brain responses as a confound), with one picture category indi-
cating one condition, respectively. During each trial, participants ﬁrst
saw a picture from one of the three categories (cue; 1000 ms) showing
that they could either win or avoid losing different amounts of money
(gain condition with +0.50€: n = 30 per run; loss condition with
−0.50€: n = 30 per run; high gain condition +10.00€: n = 6 per
run; high loss condition−10.00€: n=6per run) or that they should re-
spond despite no monetary outcome (±0.00€, irrespective of the re-
sponse: n = 30 per run). After a variable ﬁxation delay of 500–
3500 ms, participants were prompted to perform a simple arithmetic
task correctly and to respond within a time window of 2 s, answering
if the presented one-digit number (1, 2, 3, 4, 6, 7, 8, 9) was larger or
smaller than 5 via button press (target; 520–600ms). Feedback follow-
ed after a further variable ﬁxation delay of 500–3500 ms. Incorrect, too
slow, or omitted responses all resulted in neutral feedback in the gain
condition and in negative feedback in the loss condition. Exceptions
were the rare high gain and high loss trials, in which feedback was
given independently of subjects' responses. The next trial started after
a delay of 1000–4000 ms.
In the rewarded trials, feedback consisted of either a green arrow
pointing up indicating a gain or a grey double-arrow pointing sideways
indicating no gain. In the loss trials, a grey double-arrow pointing side-
ways indicated successful avoidance of losing money, and a red arrow
pointing down indicated a loss. In neutral conditions, feedback always
consisted of the grey double-arrow pointing sideways. To obtain ap-
proximately equal winning rates across the cohort, task difﬁculty was
adapted throughout the experiment. Initially, a response deadline was
set based on the reaction times collected during the practice session
prior to scanning, and this deadlinewas continuously and automatically
adapted for each condition throughout the experiment, such that eachparticipant would succeed on approximately 66% of their target
responses.
High gain and high loss trials were introduced to investigate the po-
tential presence of abnormal prediction errors to unexpected events in
BPD as compared to healthy controls and were intermixed randomly.
In these trials, either three green arrows pointing up (in gain trials) or
three red arrows pointing down were presented in the feedback phase
indicating a high gain or loss (±10.00€), independent of participants'
actual performance. Participants were previously informed about the
possibility of such feedback, but were unaware about the exact number
of presentations and that it was unrelated to their performance. The
inter-stimulus interval (ISI) was jittered using a near-exponential jitter
(ISI range: 3950–12,950 ms), to improve estimation of the trial-speciﬁc
blood oxygen level-dependent (BOLD) responses (Hinrichs et al., 2000).
2.3. fMRI data acquisition
MRI data were acquired on a 3 Tesla Siemens Tim Trio MR
tomograph located at the Dahlem Institute for Neuroimaging of Emo-
tion (D.I.N.E.; Research Center Languages of Emotion, Free University of
Berlin) equipped with a 12-channel phased-array head coil with
whole brain coverage. Functional MRI datawere acquired using a gradi-
ent, T2*-weighted echo-planar imaging (EPI) sequence. Thirty-seven
adjacent axial slices were acquired along the anterior commissure/pos-
terior commissure (AC-PC) plane in ascending order,with a 64× 64ma-
trix and 192 mm ﬁeld of view (voxel size 3 × 3 × 3 mm, TR = 2000,
TE= 30, ﬂip angle= 70). Prior to fMRI data collection, a 3D T1-weight-
ed MPRAGE image (voxel size = 1 × 1 × 1 mm; TR = 1900 ms; TE =
2.52 ms) and a co-planar proton density (PD)-weighted MR image
(voxel size = 0.7 × 0.7 × 2 mm; TR = 2740ms; TE= 8.2 ms) were ac-
quired. The MPRAGE image was used for orientation of the EPIs along
the AC-PC line, and the PD-weighted image was employed to improve
spatial normalization of subcortical structures (see below).
2.4. Data processing and analysis
2.4.1. Behavioral data analyses
Behavioral data were analyzed using SPSS (IBM, Armonk, NY, USA)
and Matlab (Mathworks Inc., Natick, MA) and consisted of mean reac-
tion times (mean value of all correct but not RT thresholded trials)
Table 3
Behavioral results of the fMRI study.
RT (ms) Accuracy
HC BPD HC BPD
Condition
Neutral 599.03 (85.66) 557.14 (67.14) 0.966 (0.03) 0.942 (0.05)
Gain 569.29 (90.07) 548.94 (69.94) 0.964 (0.03) 0.950 (0.05)
Loss 575.42 (102.89) 555.23 (66.54) 0.955 (0.03) 0.935 (0.05)
Mean response times (RT) and accuracy in the three conditions of interest in the BPD pa-
tients (BPD) and the control group (HC). Standard deviations are given in parentheses.
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abs(digit-5)) and accuracy rates (proportion of correct responses over
all trials per condition) for each subject.
2.4.2. fMRI data processing and analyses
Functional MRI data processing and analysis were performed using
Matlab and the Matlab-based Statistical Parametric Mapping software
package (SPM8, Wellcome Trust Center for Neuroimaging, London,
UK; http://www.ﬁl.ion.ucl.ac.uk/spm/). EPIs were ﬁrst corrected for ac-
quisition delay (slice timing) and head motion (realignment) using the
algorithms implemented in SPM. To optimize spatial normalization,
the co-planar PD image was then co-registered to the mean EPI obtain-
ed from motion correction. We used PD images as they provide a good
grey/white matter contrast in subcortical regions like the VS/NAcc
(D'Ardenne et al., 2008; Schott et al., 2008). The PD imagewas then seg-
mented into grey matter, white matter, and cerebrospinal ﬂuid using
the segmentation algorithm provided by SPM, and EPIs were warped
into a standard stereotactic reference space (Montreal Neurological In-
stitute, MNI) using the normalization parameters obtained from seg-
mentation (ﬁnal voxel size = 3 × 3 × 3 mm). Normalized EPIs were
smoothed with a Gaussian kernel of 8 mm3 FWHM. Finally, a 1/128 Hz
temporal high-pass ﬁlter was applied to the data to remove low-fre-
quency noise.
For statistical analysis a two-stage mixed effects model was applied.
In the ﬁrst stage, individual general linear models (GLMs) were set up
for each subject. GLMs contained separate regressors for the conditions
of interest [cues: gain, (avoidable) loss, neutral; feedback: gain, loss, high
gain, high loss, no gain, avoided loss, predicted neutral feedback; target
numbers; all convolved with the canonical hemodynamic response
function implemented in SPM] and further covariates of no interest for
the six rigid-body transformations obtained from motion correction,
plus a single constant (the mean over scans).
After conﬁrming sufﬁcient variance explanation by the model
employed at the ﬁrst level (Supplementary Fig. S1), second-level ran-
dom effects analyses were then computed over the single subjects' con-
trasts. To this end, single subjects' contrasts of interest [gain
anticipation: gain cues – neutral cues; loss anticipation: loss cues – neu-
tral cues] were submitted to a random effects ANOVA model including
age as covariate of no interest. Planned comparisons were carried out
by means of T contrasts on the regressors of the second level GLMs.
The signiﬁcance levelwas set to p b 0.05,whole-brain corrected for fam-
ily-wise error rate (FWE) in all within-group analyses (see Supplemen-
tary Tables S1–S6).
Because of our a priori anatomical hypothesis regarding the role of
the striatum in human reward processing and its relationship to impul-
sivity, we performed a between-group region of interest (ROI)-based
analyses in the striatum, with an anatomical ROI obtained from the
WFU Pickatlas (Wake Forest University; http://fmri.wfubmc.edu/
software/pickatlas) and a signiﬁcance level of p b 0.05 FWE corrected
for the ROI volume. SPM betas at the local maximum within the VS/
NAcc were also submitted to bootstrap-based conﬁdence interval esti-
mation. For exploratory whole-brain between-group analyses, the sig-
niﬁcance level was set to p b 0.001, uncorrected, and activations
surviving cluster-level FWE correction are marked as such.
Correspondence between brain structures and activation foci were
determined using the Automated Anatomical Labeling (Tzourio-
Mazoyer et al., 2002) as implemented in the WFU Pickatlas.
2.4.3. Brain-behavior correlations
To investigate the relationship between striatal responses tomotiva-
tional cues (gain, loss) and self-reported impulsivity as assessed with
the Barratt Impulsiveness Scale (BIS-11), we computed a contrast of
the additive effect of diagnostic group and motivation (i.e., main effect
of group [(gain-neutralHC AND loss-neutralHC) vs. (gain-neutralBPD
AND loss-neutralBPD)], inclusively masked with the positive effect of
motivation [(anticipate gain N anticipate neutral)HC AND (anticipategain N anticipate neutral)HC] AND (anticipate loss N anticipate
neutral)HC AND (anticipate loss N anticipate neutral)HC)]) and extracted
participants' contrasts of parameter estimates of each condition at the
peak voxel within the VS/NAcc. These values were correlated with indi-
vidual BIS-11 scores using Sheperd's Pi correlations. Shepherd's Pi corre-
lations have recently been proposed to improve robustness of brain-
behavior correlations. They are based on Spearman's non-parametric
correlation, but additionally include a bootstrap-based estimation of
the Mahalanobis distance, thereby allowing for an unbiased removal
of outliers (Schwarzkopf et al., 2012). Because, in addition to higher
BIS-11 scores, patients had substantially higher BDI scores reﬂecting de-
pressive symptoms (Table 1), Shepherd's Pi correlationswere also com-
puted between striatal anticipation responses and BDI scores, and





Mean scores of the BIS-11, BDI, and BSL are displayed in Table 1, sep-
arated by diagnostic group. In line with our predictions, BPD patients
exhibited higher BIS-11 scores compared to healthy controls. Addition-
ally, patients showed signiﬁcantly higher BDI scores, reﬂecting depres-
sive symptoms, and BSL scores, reﬂecting BPD-related
psychopathology. On the other hand, the groups were highly compara-
ble with respect to tests of ﬂuid (LPS) and crystalline (MWT)
intelligence.
3.1.2. Accuracy
Mean reaction times and accuracy rates for both groups are present-
ed in Table 3. Because Kolmogorov-Smirnov (KS) tests with Lilliefors
signiﬁcance correction (Lilliefors, 1967) applied to accuracy rates indi-
cated a signiﬁcant deviation from the normal distribution, non-para-
metric testing procedures were adopted for accuracy rates
(Friedman's tests for within-subject comparisons and Mann-Whitney
U tests for between-subject comparisons). The non-parametric tests re-
vealed a trend for a between-group difference in accuracy during neu-
tral trials only (p = 0.100; Mann-Whitney U test) and a further trend
for an unequal distribution of accuracies in the patient group (p =
0.096; Friedman test), most likely reﬂecting lower accuracy in the pa-
tient group during neutral trials. No further trends for within-group or
between-group differences in accuracy rates were observed (all
p N 0.162).
3.1.3. Reaction times
The distribution of RTs did not depart signiﬁcantly from the predict-
ed normal distribution in any of the conditions (KS tests with Lilliefors
signiﬁcance correction), neither in the control nor in the BPD group
(all p N 0.127). We thus compared the average RTs (corrected for task
difﬁculty (=abs(digit-5))) using an ANCOVA for repeated measures
(within-subject factor condition – reward, (avoidance of) loss, and neu-
tral; between-subject factor group; age as covariate). Degrees of free-
dom were corrected using Greenhouse-Geisser correction to account
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(F1.71,70.11 = 4.57, p = 0.018), reﬂecting the shorter RTs in motivated,
particularly rewarded, trials (Table 3). Moreover, a signiﬁcant condition
by age interaction (F1.71,70.11= 4,49, p=0.019) and a trend for a condi-
tion by group interaction (F1.71,70.11 = 3.08, p= 0.060) were observed,
with the lattermost likely reﬂecting the fact that patients had nominally
shorter RTs, but lower RT differences between motivated and neutral
trials (Table 3).
3.2. Functional MRI results
3.2.1. Effects of motivational salience
A comparison of brain responses to cue pictures signaling a reward
or avoidable loss [positive effect of gain anticipation; (anticipate
gain N anticipate neutral)HC AND (anticipate gain N anticipate
neutral)BPD] elicited widespread activations within the mesolimbic re-
ward system, including the ventral and dorsal striatum, the dorsal ante-
rior cingulate cortex, extending into the supplementary motor area
(dACC/SMA) and the thalamus (p b 0.05, whole-brain FWE-corrected;
see Supplementary Table S1), replicating previous results (Wittmann
et al., 2005; Schott et al., 2007). Similarly, anticipation of avoidable
losses [positive effect of loss anticipation; (anticipate loss N anticipate
neutral)HC AND (anticipate loss N anticipate neutral)BPD] also engaged
the striatum and prefrontal neocortical structures in both groups, in-
cluding the dACC/SMA (p b 0.05, whole-brain FWE-corrected; Supple-
mentary Table S2).
Reward feedback (gain - neutral) was associated with an increased
activation of the VS/NAcc whereas loss feedback (loss - neutral) elicited
a deactivation of the VS/NAcc (F-contrast testing reward feedback
against loss feedback across groups; Supplementary Fig. S2). An explor-
atory ANCOVA model testing for potential effects of the high gains or
losses revealed no reliable activation differences between high gains
or losses and standard gain or loss feedback, respectively.
3.2.2. Reduced striatal anticipation responses in BPD patients
While computing the gain and loss anticipation contrasts separately
for healthy controls and BPD patients, we observed reliable mesolimbic
(i.e., ventral striatal and midbrain) activations during gain, but not loss
anticipation in the patients (at p b 0.05, whole-brain FWE-corrected;
Fig. 2). In an exploratory analysis at a more liberal signiﬁcance level
(p b 0.001, uncorrected), BPD patients exhibited activation of theFig. 2. Functional MRI correlates of gain and loss anticipation in healthy controls and BPD pat
activation of the midbrain (substantia nigra / ventral tegmental area, slice 1, 4), the VS/NAc
striatal activation was observed during gain anticipation (slice 1, 2), but did not survive who
during anticipation of losses (slices 4–6). All activation maps are thresholded at p b 0.05, wholstriatum, themidbrain, and the dACCduring both gain and loss anticipa-
tion (details available upon request), suggesting that the activation dif-
ference observed was a quantitative rather than qualitative one.
A direct comparison of the anticipation responses to rewards and
losses in healthy controls and BPD patients [(gain-neutralHC AND loss-
neutralHC) vs. (gain-neutralBPD AND loss-neutralBPD)] showed a signiﬁ-
cantly reduced activation of the VS/NAcc in the patient group (left: [x
y z] = [−15 17–5], T= 4.01, p= 0.044, FWE-corrected for ROI of the
bilateral striatum; right: [x y z]= [9 8 1], T=4.15, p=0.028, small-vol-
ume FWE-corrected; see Fig. 3). Including smoking status (coded as
0 = never-smoker, 1 = former or occasional smoker, 2 = current
smoker) as a covariate in the GLM did not qualitatively affect the
group difference in the striatum. Bootstrap-based estimation of the
90% conﬁdence intervals further showed that, in BPD patients, the me-
dian ventral striatal activation during gain anticipation was below the
5th percentile of the healthy controls' median, and that the 90% conﬁ-
dence intervals of themedian parameter estimates during loss anticipa-
tion did not overlap between healthy controls and BPD patients (Fig. 3,
left panel) [Note: Despite the bootstrap-based conﬁdence interval esti-
mation suggesting a more pronounced between-group difference for
loss anticipation versus gain anticipation, the formal group-by-motiva-
tion interaction contrast revealed no signiﬁcant activation clusters in
the striatum, even at p b 0.005, uncorrected].
An exploratory analysis of between-group differences at p b 0.001,
uncorrected, additionally revealed reduced prefrontal and occipital cor-
tical activations during gain and loss anticipation in BPD patients
(Table 4). Notably, in this exploratory analysis, only the activation dif-
ference in the right striatum remained signiﬁcant after whole-brain
FWE correction at cluster level, and a trend towards signiﬁcance after
cluster-level FWE correction was observed in the left striatum.
During feedback, both groups exhibited positive ventral striatal pre-
diction errors to gains and negative striatal prediction errors to losses,
but there was no signiﬁcant between-group difference with respect to
striatal prediction errors (Supplementary Fig. S2). An exploratory anal-
ysis revealed an increased activation of the hippocampus in patients,
but not in controls, during positive feedback (main effect of group:
F1,81 = 37.27; p= 0.002, whole-brain FWE-corrected).
3.2.3. Correlation of striatal anticipation responses and impulsivity
To test how altered anticipation of gains and/or losses in BPD pa-
tients might be related to self-reported individual impulsivity, weients. Top: In healthy controls, anticipation of both gains and losses was associated with
c (slice 2, 5), and the dACC (slice 3, 6). Bottom: In BPD patients, midbrain and ventral
le-brain FWE correction in the dACC (slice 3), while the reverse activation was observed
e-brain FWE corrected.
Fig. 3. Reduced ventral striatal anticipation of gains and losses in BPD patients. Left: Maximum of the ventral striatal between-group difference during the anticipation of gains and losses
(p= 0.028, small-volume FWE-corrected for the bilateral striatum), inclusively masked with the positive effect of motivational salience (anticipate gain-neutral and anticipate loss-
neutral) is displayed, thresholded at p b 0.001, uncorrected, for illustrative purposes. Plots depict median contrasts of parameter estimates (SPM betas) of the conditions of interest
(anticipate gain-neutral and anticipate loss-neutral, separated by group) at the peak voxel of the group difference ([x y z] = [9 8 1]); error bars display 90% conﬁdence intervals of the
medians as estimated via bootstrap resampling.
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tistic robust to outliers (Schwarzkopf et al., 2012). As displayed in Fig. 4,
controls exhibited a positive correlation between BIS-11 total scores
and the ventral striatal anticipation responses to both gains and losses
(gains: π= 0.55, p = 0.031; losses: π= 0.55, p = 0.018). In the pa-
tients, the correlation between striatal gain anticipation and impulsivity
was not signiﬁcant, albeit also positive in sign (π= 0.23; p = 0.657).
When correlation coefﬁcients between patients' and controls' responses
to gains and impulsivity were directly compared, however, no signiﬁ-
cant difference between groups was found (Fisher's Z = 1.09; p =
0.276, two-tailed).
Most notably, the correlation between striatal loss anticipation re-
sponses and impulsivity scoreswas signiﬁcantly negative in the patients
(π = −0.59; p = 0.012). Fisher's Z test conﬁrmed a signiﬁcant be-
tween-group difference between the correlation coefﬁcients of ventral
striatal loss anticipation and impulsivity (Z = 3.99; p = 0.0001).
[Note:when computing Spearman's correlationswithout outlier remov-
al, the signs and signiﬁcance levels of all correlations did not change
substantially]. The correlations did not change qualitatively in direction
or signiﬁcance when the parameter estimates in the VS/NAcc were ad-
justed for smoking status.
Unlike impulsivity, depressive symptoms as assessed with the BDI
did not correlate with striatal anticipation of gains or losses in either
BPD patients or healthy controls (all p N 0.407). When, separately for
controls and BPD patients, both BDI and BIS-11 scores were entered
into linear regression analyses with striatal anticipation responses as
the dependent variable, BIS-11 was negatively associated with striatalTable 4
fMRI between-group activation differences during gain and loss anticipation.
x y z t k pFWE,cluster
Left inferior frontal gyrus −33 8 25 5.03 23 0.366
Left middle frontal gyrus −27 5 52 3.88 12 0.720
−30 8 40 3.80
Right striatum 12 5 −2 4.44 105 0.003⁎⁎
Right superior occipital gyrus/cuneus 18 −85 19 4.25 20 0.446
18 −88 7 3.22
Left striatum −15 17 −5 4.01 45 0.084⁎
−9 5 −5 3.45
Peak activations at the local maxima are displayed at p b 0.001, uncorrected; k = cluster
size; pFWE,cluster = signiﬁcance level corrected for family-wise error rate at cluster level.
⁎⁎ p b 0.01, FWE-corrected at cluster level.
⁎ p b 0.10, FWE-corrected at cluster level.loss anticipation responses in BPD patients (βBIS-11 = −0.514, p =
0.017), whereas BDI scores did not explain a signiﬁcant proportion of
the variance in either group or condition (all abs(βBDI) b 0.147, all
p N 0.490). Furthermore, correlating depressiveness and striatal antici-
pation responses across the entire cohort yielded no effect of BDI scores
when covarying for diagnostic group.
4. Discussion
The goal of our present studywas to uncover potential neuralmech-
anisms underlying dysfunctional anticipation of rewards and losses in
borderline personality disorder and their potential relationship to im-
pulsivity. In line with previous studies (Völlm et al., 2007; Enzi et al.,
2013), we observed reduced activation of the VS/NAcc during the antic-
ipation of gain and loss in a homogenous sample of unmedicated female
BPD patients in comparison to an age-matched healthy control group
with comparable cognitive ability. In line with our hypotheses, BPD pa-
tients compared to healthy controls exhibited higher self-reported im-
pulsivity scores as measured with the Barratt Impulsiveness Scale
(BIS-11). Brain-behavior correlation analyses revealed positive correla-
tions between the ventral striatal anticipation responses to both gains
and losses and BIS-11 total scores in the control group, while patients,
on the other hand, showed no signiﬁcant correlation of striatal gain an-
ticipation and impulsivity, but exhibited a signiﬁcantly negative correla-
tion between striatal loss anticipation responses and BIS-11 scores.
4.1. Reduced ventral striatal anticipation responses in BPD and other psy-
chiatric disorders
The ﬁnding of unmedicated female BPD patients exhibiting a rela-
tively reduced activation of the VS/NAcc during anticipation of reward
– and also losses – is consistent with previously observed reduced VS/
NAcc reward responses in male Cluster B patients (Völlm et al., 2007)
and in a sample of BPD patients comparable to that of the present
study (Enzi et al., 2013). Reduced ventral striatal activations during
rewarded tasks, most prominently monetary incentive delay (MID)
task adaptions (Knutson et al., 2001), have previously been described
in a number of patient populations with other psychopathologies, in-
cluding alcohol-dependent patients (Wrase et al., 2007; Beck et al.,
2009), unmedicated patients with schizophrenia (Juckel et al., 2006),
patients with schizophrenia receiving typical neuroleptics
(Schlagenhauf et al., 2008), and patients with ADHD (Ströhle et al.,
Fig. 4. Correlation of striatal anticipation responseswith impulsivity. A: Left panel: Controls exhibited a positive correlation between the ventral striatal ([x y z]= [9 8 1]) gain anticipation
response and impulsivity (as reﬂected by the BIS-11 sum score; π= 0.55, p = 0.031). Right panel: In the patients, this correlation was also positive, but failed to reach statistical
signiﬁcance (π= 0.23; p = 0.671). B: While controls showed a signiﬁcant positive correlation between the striatal loss anticipation response and the BIS-11 sum score (left panel;
π= 0.55, p = 0.018), the correlation was signiﬁcantly negative in patients (right panel; π=−0.59; p = 0.012). Note: One control subject had a beta value of N500, resulting in an
outlier that is not displayed in the ﬁgure.
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2014). This is in apparent contrast to the observation that patients
with addictions, ADHD, or Cluster B personality disorders like BPD com-
monly show a high propensity to actively seek rewards, and particularly
short-term rewarding experiences at the expense of long-term goals
(Sonuga-Barke, 2005; Svaldi et al., 2012). One rather parsimonious ex-
planation for this phenomenon would be that reduced neural respon-
siveness to reward-associated stimuli might provoke increased
reward-seeking behavior as a means of compensation, as described in
patients with pathological gambling (Reuter et al., 2005).
Such an explanationwould be based on the assumption that reduced
VS responses might constitute a neural signature of pathological impul-
sivity or related phenotypes. There is, however, a considerable body of
literature reporting alterations of ventral striatal reward processing in
a number of psychiatric disorders inwhich impulsivity is not considered
a prominent feature (Hägele et al., 2015), and also in normal aging. In
the healthy elderly, reduced striatal anticipation responses to losses
(Samanez-Larkin et al., 2007), but also gains (Schott et al., 2007; Mell
et al., 2009; Eppinger et al., 2013) have been commonly reported,
whereas BIS-11 normative data suggest that –at least self-reported– im-
pulsivity decreases with age (Spinella, 2007). Considering this discrep-
ancy, one should keep in mind the possibility that blunted ventral
striatal anticipation responses in aging and in psychiatric disorders
may constitute a common outcome of a number of distinct
neurocognitive mechanisms. At a neural level, this phenomenon may
be mediated by differential structural and functional alterations of themesolimbic dopamine system in the elderly and in different psychiatric
patient populations. Mesolimbic reward prediction and reward-based
learning are intimately linked to dopaminergic neurotransmission
(Pessiglione et al., 2006; Schott et al., 2008), and older adults show rel-
atively symmetric reductions of presynaptic dopamine synthesis and
release capacity, and of postsynaptic dopamine D2 receptor expression,
whichhave been linked to age-related cognitive decline (Bäckmanet al.,
2006) and also altered reward processing (Dreher et al., 2008). In psy-
chiatric patient populations, functional neuroanatomical alterations of
the dopamine system are commonly asymmetric with, for example, al-
cohol-dependent patients showing reduced postsynaptic D2 receptor
binding capacity (Heinz et al., 2004), but presynaptic dopamine trans-
porter binding comparable to healthy controls (Heinz et al., 2005). Pa-
tients with schizophrenia, on the other hand, have been shown to
exhibit increased presynaptic dopamine release capacity when com-
pared to healthy controls (Breier et al., 1997; Goto and Grace, 2007).
The aforementioned studies collectively suggest that themesolimbic re-
ward system is sensitive to a variety of dysregulations in themesolimbic
dopaminergic system,with profound impact onmotivated behavior, in-
cluding reinforcement learning, novelty processing, or decision-making
(Camara et al., 2009). Conversely, switching patients with schizophre-
nia from typical to atypical neuroleptics has been associated with a par-
tial restoration of the VS/NAcc reward anticipation (Schlagenhauf et al.,
2008, 2010) and, similarly, a relative normalization of the striatal gain
anticipation response in ADHD under methylphenidate treatment has
been reported (Aarts et al., 2015).
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processing to thepathogenesis of thedisorder has received considerable
theoretical interest in recent years. Disturbances of the endogenous opi-
oid system – a key transmitter system in motivated behavior – have
been suggested to constitute an important pathophysiological mecha-
nism in BPD (Stanley and Siever, 2010), with the dysfunctional behav-
iors of the affected patients being driven by unconscious attempts to
stimulate their endogenous opioid system – and thereby also indirectly
the dopaminergic reward system. Evidence of dysregulation of regional
endogenous opioid function in BPD supports this hypothesis (Prossin et
al., 2010). Dopaminergic system dysfunction was suggested to play a
role in BPD as early as 2004 (Friedel, 2004) and has been implicated in
three dimensions of the disorder: emotional dysregulation, impulsivity,
and cognitive-perceptual impairment like dissociative states. However,
thus far little empirical evidence exists for dysfunctions in the
mesolimbic dopamine system in BPD. Ventral striatal BOLD signals dur-
ing reward processing have been associated with individual dopamine
release capacity in healthy humans (Scott et al., 2007; Schott et al.,
2008; Buckholtz et al., 2010), although this relationship may be
disrupted in patients with certain psychiatric disorders like schizophre-
nia (see Breier et al., 1997 vs. Juckel et al., 2006) or pathological gam-
bling (see Boileau et al., 2013 vs. Reuter et al., 2005). In BPD patients,
a recent event-related brain potential (ERP) study (Schuermann et al.,
2011) has shown a reduced amplitude of the feedback-related negativ-
ity (FRN) during performance of the Iowa Gambling Task. The dynamics
of the FRN have been suggested to indirectly reﬂect a temporary reduc-
tion of midbrain dopaminergic activity in response to unexpected aver-
sive outcomes (Schultz, 1998). Together with the previous observations
by Völlm et al. (2007) as well as Enzi et al. (2013), our results provide
further evidence for dysfunction of the dopaminergic system in BPD.
While reduced anticipation responses to gains have been extensive-
ly documented in several different psychiatric patient populations, al-
terations of the striatal loss anticipation have been investigated less
frequently. Increased ventral striatal loss anticipation responses have
been reported in pathological gamblers, but not in alcohol-dependent
patients and might therefore constitute a relatively disorder-speciﬁc
mechanism in pathological gambling (Romanczuk-Seiferth et al.,
2015). Reduced anticipation responses to (avoidable) losses have been
reported in patients with MDD or bipolar II disorder (Ubl et al., 2015;
Yip et al., 2015). Indeed, patients with BPD, including our sample, com-
monly exhibit depressive symptoms, and the potential contribution of
depression-related psychopathology will be discussed below. Further-
more, as anticipation responses to both gains and losses are subject
menstrual cycle-dependent hormonal changes in women (Bayer et al.,
2013), the previously reported hormonal dysregulations in female
BPD patients (Roepke et al., 2010; Eisenlohr-Moul et al., 2015) may
also have contributed to the reduced ventral striatal anticipation re-
sponse in our patient sample.
One limitation of the present study is that, while the separate analy-
ses of gain and loss anticipation in healthy controls and BPD patients
suggest that the patients also exhibited reduced anticipation responses
in cortical regions like the dACC (Fig. 2), a direct between-group com-
parison revealed a robust between-group difference only in the stria-
tum (Fig. 3, Table 4). We cannot exclude that this may result from
insufﬁcient statistical power in brain regions outside the striatum, and
it is indeed plausible to assume that reduced VS/NAcc activation during
reward anticipation would likely be accompanied by decreased activa-
tion of other nodes within the reward-responsive network, including
cortical regions like the dACC and the insula.
From a pharmacological perspective, little is thus far known about
the clinical potential of addressing the suspected dopaminergic system
dysfunction in BPD patients. A few studies, however, suggest that
certain atypical antipsychotic agents may exert a beneﬁcial effect on
symptom control in BPD patients. For example, aripiprazole, a partial
agonist onD2 type dopamine receptors that has been shown to enhance
the VS reward anticipation response in patients with schizophrenia(Schlagenhauf et al., 2010), can improve symptoms of depression, anx-
iety, and anger in BPD patients (Nickel et al., 2006). Given the clinical
heterogeneity of BPD, future research should be directed at the identiﬁ-
cation of a potential subpopulation of BPD patients whomight show the
most pronounced clinical beneﬁt from such an intervention.
4.2. The relationship between ventral striatal loss prediction and impulsiv-
ity in BPD
As predicted, self-reported impulsivity, indexed by theBIS-11 scores,
were signiﬁcantly higher in the BPD patientswhen compared to healthy
controls. When correlating the activation during anticipation of gains
and losses with BIS-11 scores, different patterns were observed in BPD
patients and healthy controls. Healthy control participants showed a
positive correlation between BIS-11 scores and VS/NAcc gain anticipa-
tion responses, which is in line previous studies (Plichta and Scheres,
2014). Unmedicated female BPD patients, on the other hand, showed
a non-signiﬁcant positive correlation between BIS-11 scores and gain
anticipation, and, more importantly, exhibited a negative correlation
between impulsivity and the VS/NAcc responses to loss anticipation.
This pattern differs markedly from previous studies in other psychiatric
patient populationswith increased trait impulsivity like alcohol-depen-
dent patients (Beck et al., 2009) or patients with ADHD (Scheres et al.,
2007), which have reported negative correlations between VS/NAcc
gain responses and self-reported impulsivity. While impulsivity has
been previously suggested to constitute a neurocognitive phenomenon
common to BPD and substance use disorders (Bornovalova et al., 2005),
the discrepancy across diagnostic groups with respect to correlation
with VS/NAcc responsivity suggests that self-report measures of impul-
sivity in these different clinical populationsmight reﬂect, at least partly,
dissociable entities. Like patientswith ADHDor substance use disorders,
BPD patients tend to make unfavorable choices despite possessing de-
clarative knowledge about the long-term aversive consequences
(Svaldi et al., 2012). At the same time, BPDpatients, somewhat paradox-
ically, also show high levels of self-reported harm avoidance (Fassino et
al., 2009).
In our study, BPD patients who exhibited higher VS/NAcc responses
to loss cues reported lower impulsivity as assessedwith the BIS-11. One
might thus argue that among BPD patients, who generally have a pro-
pensity to make risky choices without considering potential harmful
outcomes (Svaldi et al., 2012), those who describe themselves as less
impulsive could bemore receptive to negative reinforcement and there-
fore process avoidable losses in a similar way as potential gains. On the
other hand, the simultaneous presence of high harm avoidance and el-
evated impulsivity in BPD patients might compromise these patients'
capacity to cope with aversive outcomes of their actions, possibly caus-
ing higher emotional distress, which may then give rise to self-destruc-
tive behaviors in BPD patients. In this context, it must be kept in mind
that the term “impulsivity” is somewhat poorly deﬁned and, in BPD pa-
tients, might potentially refer to (at least) two distinct phenomena: On
the one hand, BPD patients are highly sensitive to emotionally aversive
events, and negative emotional experience commonly trigger impulsive
behavior (Brown et al., 2002; Crowell et al., 2009; Trull et al., 2008). This
type of “impulsivity” might be relatively speciﬁc to BPD, further re-
search is necessary to establish clinical tools that would be better-suited
to quantify this phenomenon. On the other hand, “impulsivity” as
assessedwith the BISmight reﬂect a trait that is common to several psy-
chiatric disorders, including addiction or ADHD.
There is limited previous evidence with respect to altered loss pro-
cessing in BPD patients and a potential relationship with impulsivity.
One study in male Cluster B patients reported a negative relationship
between the processing of monetary gain and impulsivity in the pre-
frontal cortex, but no correlation was reported in the striatum (Völlm
et al., 2007). One reason for the lack of a negative correlation between
impulsivity and ventral striatal reward signals in the study by Völlm
and colleagues might be that their patient sample was substantially
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erably, as Völlm and colleagues investigated only male participants,
some of whom had been diagnosed with an antisocial rather than bor-
derline personality disorder, and manifestations of impulsivity can dif-
fer between these two disorders (DeShong and Kurtz, 2013). On the
other hand, in a sample clearly distinct from our study sample, but
more comparable to the sample investigated by Völlm and colleagues,
a similar pattern as observed here has previously been reported: In a co-
hort of prison inmates with high psychopathy scores measured via the
Psychopathy Check List – Revised (PCL-R; Hare, 2003) who were
compared to prisoners with low psychopathic traits (Pujara et al.,
2014), a positive correlation of the striatal response difference
between gain and loss feedback and the overall psychopathy score
was observed selectively in the individuals with high PCL-R scores.
Notably, this relationship resulted largely from a negative correla-
tion of PCL-R scores and striatal loss responses, compatible with
previously reported deﬁcits in the anticipation of aversive outcomes
in individuals with psychopathic traits (Prehn et al., 2013). Regard-
ing the widely used two-factor model of psychopathy implemented
in the PCL-R, BPD patients typically show low scores on Factor 1
(blunted affect, stress immunity, narcissism), while they score high
on Factor 2 (impulsivity, boredom susceptibility, aggressiveness)
(Hunt et al., 2015). In the study by Pujara et al. (2014), overall PCL-
R scores showed a more robust correlation with the ventral striatal
BOLD response during loss processing than either factor alone, and
the analogy in the results of the two studies must be interpreted
with caution [Note: In the course of the preparation of this article,
we re-analyzed the data from Pujara et al., 2014, using Shepherd's
Pi correlations, which did not affect the previously reported results
(details available upon request).]. With respect to the clinic, the ob-
served similarity of the results would nevertheless be in line with the
dysfunctional behavioral patterns observed in both populations,
namely a problematic preference for risky choices, risk taking with-
out fear of consequences, and frequently experienced frustration
due to negative consequences of one's own behavior, all of which
are in turn commonly associated with emotional dysregulation.
Given the previously suggested common genetic basis for impul-
sivity across personality disorders (Kendler et al., 2008), it is tempt-
ing to conclude that impulsivity might largely result from a reduced
ability to predict aversive outcomes [Note:While psychopathy is not
a personality disorder per se, the construct as implemented in the
PCL-R shows a well-known diagnostic overlap with antisocial per-
sonality disorder, and also other Cluster B personality disorders,
most prominently narcissistic and histrionic personality disorder
(Hare and Neumann, 2005; Blackburn, 2007)]. However, additional
factors must not be neglected. Importantly, studies in healthy partic-
ipants suggest that individual levels of impulsivity (Plichta and
Scheres, 2014) or psychopathic traits (Buckholtz et al., 2010) are
positively correlated with the anticipatory response to gains, a rela-
tionship also observed in inmates with pathological psychopathy
scores (Pujara et al., 2014). These ﬁndings suggest that –rather
than impaired loss processing alone– a dysfunctional bias of the
responsivity of the mesolimbic dopaminergic system towards the
processing of rewards in comparison to losses might constitute a
more accurate description of a motivation-related neural mecha-
nism underlying clinically relevant levels of impulsivity.
Despite apparently similar mechanisms with respect to impaired
loss processing, it must be kept in mind that BPD and psychopathy are
clinically distinct entities. One fundamental difference between BPD pa-
tients and individuals with high trait psychopathy concerns the role of
depressive symptomatology, with psychopathic traits –particularly
those deﬁned by Factor 1– being negatively related to depressive symp-
toms (Berg et al., 2015), whereas BPD patients almost invariably show
severe depressive symptoms. A potential contribution of depressive
symptomatology to altered gain and loss processing in BPD will be
discussed in the following paragraph.4.3. Ventral striatal reward processing and depressive symptoms in BPD
An additional, or alternative, explanation for the reduced anticipa-
tion responses to gains and losses in the patient group may be related
to the presence of considerable depressive symptomatology in BPD pa-
tients. In fact, almost all BPD patients show considerable depressive
symptomatology, and comorbidity with MDD is estimated to be as
high as 50 to 90% (Stanley and Wilson, 2006; Wilson, 2007; Silk, 2010;
Zanarini et al., 1998; Gunderson et al., 2000), a phenomenon also ob-
served in the sample investigated here (Tables 1, 2).
Previous studies have demonstrated reduced striatal reward antici-
pation responses in MDD patients compared to healthy controls (Stoy
et al., 2012; Arrondo et al., 2015; for a meta-analysis see Zhang et al.,
2013), and, using a dimensional approach, Hägele and colleagues dem-
onstrated a correlation between self-reported depressive symptoms
and VS/NAcc reward anticipation responses in patients from several di-
agnostic groups, including MDD, schizophrenia, ADHD, and alcohol de-
pendence (Hägele et al., 2015). Moreover, not only gain, but also loss
anticipation responses have been shown to be reduced in patients
with unipolar depression and bipolar II disorder (Ubl et al., 2015; Yip
et al., 2015). It is thus conceivable that the between-group differences
in striatal gain and loss anticipation might in part be related to depres-
sive symptoms.
On the other hand, unlikeMDDpatients (Zhang et al., 2013) the BPD
patients investigated in the present study did not differ signiﬁcantly
from healthy controls in their striatal feedback responses. This raises
the possibility that the neurobiological mechanisms underlying depres-
sive symptoms in BPD and their relationship between gain and loss pro-
cessingmight, at least in part, differ from those inMDD. In linewith this
notion, BDI scores did, despite the between-group difference mirroring
the fMRI results, not correlate signiﬁcantlywith either gain or loss antic-
ipation responses in the VS/NAcc in within the groups, and did also not
inﬂuence the negative correlation between BIS-11 scores and VS/NAcc
loss anticipation responses in BPD patients. We tentatively suggest
that this might be related to the clinical observation that depressive
symptoms in BPD are partly distinct from those in MDD at the clinical
level, with more pronounced cognitive symptoms like feelings of guilt
and self-devaluation, and self-reported depressiveness in BPD is typical-
ly higher than clinician-assessed depressive symptoms (Stanley and
Wilson, 2006; Wilson et al., 2007; Silk, 2010).
One potential explanation for this apparent discrepancy might be
that BPD patients are highly sensitive to social rejection (Lis and
Bohus, 2013; Domsalla et al., 2014), and aversive social interactions
are typically one of themost common causes for dysfunctional behavior
in these patients (Wagner and Linehan, 1999). An important direction
for future researchwould therefore be theuse of social rather thanmon-
etary reward and punishment conditions (Richey et al., 2014; Barman et
al., 2015), which might constitute more disorder-relevant stimuli in
BPD patients.5. Conclusion
Our results show that BPD patients exhibit reduced, but yet signiﬁ-
cantly positive, anticipation responses to anticipated rewards and losses
in the VS/NAcc. Impulsivity shows a speciﬁc negative correlation with
ventral striatal loss, but not gain, anticipation in BPD patients, whereas
depressive symptoms did not signiﬁcantly modulate striatal anticipa-
tion of gains or losses in BPD. Our results suggest that impaired
mesolimbic processing of losses may constitute a neural mechanism
that promotes the emergence of dysfunctional impulsivity and related
behaviors. In light of previous studies showing correlations between
gain anticipation and impulsivity in other psychiatric populations, our
results highlight the need for future research directed at the systematic
comparative investigation of commonly used psychopathological enti-
ties like “impulsivity” across diagnostic groups.
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